Home » Nanodx gets $18M to pursue fast, easy COVID-19, TBI tests; aims for market shortly

To read the full article sign up for free or sign in.

Nanodx gets $18M to pursue fast, easy COVID-19, TBI tests; aims for market shortly

July 2, 2020

By Stacy Lawrence

Startup Nanodiagnostics Inc. has been working for years toward a panel of point-of-care tests, helmed by one for traumatic brain injury.

BioWorld MedTech Financings Neurology/psychiatric Coronavirus Series C Diagnostics